ID   SERC5_RAT               Reviewed;         460 AA.
AC   Q63175; G3V9U9;
DT   29-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JAN-2024, entry version 134.
DE   RecName: Full=Serine incorporator 5;
DE   AltName: Full=Developmentally regulated protein TPO1 {ECO:0000303|PubMed:9326262};
GN   Name=Serinc5; Synonyms=Tpo1 {ECO:0000303|PubMed:9326262};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, INDUCTION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley; TISSUE=Telencephalon;
RX   PubMed=9326262; DOI=10.1046/j.1471-4159.1997.69041343.x;
RA   Krueger W.H.H., Gonye G.E., Madison D.L., Murray K.E., Kumar M.,
RA   Spoerel N., Pfeiffer S.E.;
RT   "TPO1, a member of a novel protein family, is developmentally regulated in
RT   cultured oligodendrocytes.";
RL   J. Neurochem. 69:1343-1355(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INDUCTION, AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=16120614; DOI=10.1074/jbc.m505712200;
RA   Inuzuka M., Hayakawa M., Ingi T.;
RT   "Serinc, an activity-regulated protein family, incorporates serine into
RT   membrane lipid synthesis.";
RL   J. Biol. Chem. 280:35776-35783(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Restriction factor required to restrict infectivity of
CC       gammaretroviruses: acts by inhibiting early step of viral infection and
CC       impairing the ability of the viral particle to translocate its content
CC       to the cytoplasm (By similarity). Enhances the incorporation of serine
CC       into phosphatidylserine and sphingolipids. May play a role in providing
CC       serine molecules for the formation of myelin glycosphingolipids in
CC       oligodendrocytes. {ECO:0000250|UniProtKB:Q86VE9,
CC       ECO:0000269|PubMed:16120614, ECO:0000269|PubMed:9326262}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q86VE9};
CC       Multi-pass membrane protein {ECO:0000255}. Note=Localizes to the cell
CC       membrane, where it is efficiently incorporated into budding
CC       gammaretrovirus virions and impairs subsequent virion penetration of
CC       susceptible target cells. {ECO:0000250|UniProtKB:Q86VE9}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q63175-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q63175-2; Sequence=VSP_033056;
CC   -!- TISSUE SPECIFICITY: Brain. Expressed at high levels in the white matter
CC       and the oligodendroglial cells of the brain. Expressed at low levels in
CC       the liver. {ECO:0000269|PubMed:16120614, ECO:0000269|PubMed:9326262}.
CC   -!- DEVELOPMENTAL STAGE: First detected in significant amounts at postnatal
CC       day 2 (P2) and increases about twofold to a peak value at P17-P20 and
CC       declines significantly thereafter. {ECO:0000269|PubMed:9326262}.
CC   -!- INDUCTION: Up-regulated during the differentiation of oligodendrocyte
CC       lineage cells and during brain development at the time of myelination.
CC       Down-regulated in the hippocampal CA fields and dentate gyrus by
CC       seizures. {ECO:0000269|PubMed:16120614, ECO:0000269|PubMed:9326262}.
CC   -!- SIMILARITY: Belongs to the TDE1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=EDM10024.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L20319; AAA41097.1; -; mRNA.
DR   EMBL; DQ103710; AAZ80297.1; -; mRNA.
DR   EMBL; AABR07007649; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07007650; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07007651; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07072694; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC130639; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473955; EDM10024.1; ALT_SEQ; Genomic_DNA.
DR   RefSeq; NP_596886.2; NM_133395.2.
DR   AlphaFoldDB; Q63175; -.
DR   SMR; Q63175; -.
DR   STRING; 10116.ENSRNOP00000060697; -.
DR   GlyCosmos; Q63175; 2 sites, No reported glycans.
DR   GlyGen; Q63175; 2 sites.
DR   PhosphoSitePlus; Q63175; -.
DR   PaxDb; 10116-ENSRNOP00000060697; -.
DR   GeneID; 170907; -.
DR   KEGG; rno:170907; -.
DR   UCSC; RGD:621571; rat. [Q63175-1]
DR   AGR; RGD:621571; -.
DR   CTD; 256987; -.
DR   RGD; 621571; Serinc5.
DR   eggNOG; KOG2592; Eukaryota.
DR   InParanoid; Q63175; -.
DR   OrthoDB; 53161at2759; -.
DR   PhylomeDB; Q63175; -.
DR   TreeFam; TF312881; -.
DR   Reactome; R-RNO-977347; Serine biosynthesis.
DR   PRO; PR:Q63175; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Proteomes; UP000234681; Chromosome 2.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0043209; C:myelin sheath; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISS:BHF-UCL.
DR   GO; GO:0051607; P:defense response to virus; ISS:UniProtKB.
DR   GO; GO:0009597; P:detection of virus; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; ISS:UniProtKB.
DR   GO; GO:0042552; P:myelination; IEP:RGD.
DR   GO; GO:0006658; P:phosphatidylserine metabolic process; IDA:HGNC-UCL.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:1904219; P:positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:1904222; P:positive regulation of serine C-palmitoyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0006665; P:sphingolipid metabolic process; ISS:HGNC-UCL.
DR   InterPro; IPR005016; TDE1/TMS.
DR   PANTHER; PTHR10383; SERINE INCORPORATOR; 1.
DR   PANTHER; PTHR10383:SF16; SERINE INCORPORATOR 5; 1.
DR   Pfam; PF03348; Serinc; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Antiviral defense; Cell membrane; Glycoprotein;
KW   Immunity; Innate immunity; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Phospholipid biosynthesis; Phospholipid metabolism; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..460
FT                   /note="Serine incorporator 5"
FT                   /id="PRO_0000330633"
FT   TOPO_DOM        1..36
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        37..57
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        58..89
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        90..110
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        111..124
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        125..145
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        146..156
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        157..177
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        178..197
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        198..218
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        219..229
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        230..250
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        251..258
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        259..279
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        280..309
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        310..330
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        331..390
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        391..411
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        412..427
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        428..448
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        449..460
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        113
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        183
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..37
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9326262"
FT                   /id="VSP_033056"
SQ   SEQUENCE   460 AA;  51856 MW;  CB9DA60F66282FB3 CRC64;
     MSARCCAGQL ACCCGSAGCA LCCGCCPKFR QSRSTRFMYL FYFTLVIIPC CVMMSPSVMK
     QMTEHIPFFE DFCKGIKAGD TCENLVGYSA VYRVCFGMAC FFFVFCVLTF KVNNSKSCRA
     SIHNGFWFFK LLLLGAMCSG AFFIPDQETF LNVWRYVGAV GSFFFICIQL LLIVEFAHKW
     NKNWTAGTVR NKLWYASLSL ALIMYSIAVG GLALMAVFYT QWDDCMDNKI LLGVHGGLCV
     LISLAAISPC VQNRQPHSGL LQPGLISCYV TYLTFSALTS KPEKVVKDEH GKNVTICVPD
     FGQDFRRDES MVTWLGTLLL VVCISYSCLT STTRSSSDAL QRRYGAPELE VARCCFCFGP
     DGEDTEEQQN VKEGPRVIYD EKKGTVYSYS YFHFVLLLAS LYVMMTLTSW FHYENATIET
     FFVGSWSIFW VKMASCWMCV LLYLWTLVAP LCCPSRQFSV
//
